Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet 383, 69–82 (2014).
Butler, A. E. et al. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52, 102–110 (2003).
Article CAS PubMed Google Scholar
Marselli, L. et al. Are we overestimating the loss of beta cells in type 2 diabetes? Diabetologia 57, 362–365 (2014).
Article CAS PubMed Google Scholar
Wu, M. et al. Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry. Cell Rep. 37, 109919 (2021).
Zaykov, A. N., Mayer, J. P. & Dimarchi, R. D. Pursuit of a perfect insulin. Nat. Rev. Drug Discov. 15, 425–439 (2016).
Article CAS PubMed Google Scholar
Rena, G., Hardie, D. G. & Pearson, E. R. The mechanisms of action of metformin. Diabetologia 60, 1577–1585 (2017).
Article CAS PubMed PubMed Central Google Scholar
Ma, T. et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603, 159–165 (2022).
Article CAS PubMed PubMed Central Google Scholar
Drucker, D. J., Habener, J. F. & Holst, J. J. Discovery, characterization, and clinical development of the glucagon-like peptides. J. Clin. Invest. 127, 4217–4227 (2017).
Article PubMed PubMed Central Google Scholar
Bailey, C. J., Tahrani, A. A. & Barnett, A. H. Future glucose-lowering drugs for type 2 diabetes. Lancet Diabetes Endocrinol. 4, 350–359 (2016).
Article CAS PubMed Google Scholar
Goode, R. A., Hum, J. M. & Kalwat, M. A. Therapeutic strategies targeting pancreatic islet β-cell proliferation, regeneration, and replacement. Endocrinology 164, bqac193 (2023).
Wagner, B. K. Small-molecule discovery in the pancreatic beta cell. Curr. Opin. Chem. Biol. 68, 102150 (2022).
Finegood, D. T., Scaglia, L. & Bonner-Weir, S. Dynamics of β-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes 44, 249–256 (1995).
Article CAS PubMed Google Scholar
Zeng, C. et al. Pseudotemporal ordering of single cells reveals metabolic control of postnatal β cell proliferation. Cell Metab. 25, 1160–1175 (2017).
Article CAS PubMed PubMed Central Google Scholar
Teta, M., Rankin, M. M., Long, S. Y., Stein, G. M. & Kushner, J. A. Growth and regeneration of adult β cells does not involve specialized progenitors. Dev. Cell 12, 817–826 (2007).
Article CAS PubMed Google Scholar
Dor, Y., Brown, J., Martinez, O. I. & Melton, D. A. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41–46 (2004).
Article CAS PubMed Google Scholar
Zhao, H. et al. Pre-existing beta cells but not progenitors contribute to new beta cells in the adult pancreas. Nat. Metab. 3, 352–365 (2021).
Article CAS PubMed PubMed Central Google Scholar
Wang, P. et al. A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication. Nat. Med. 21, 383–388 (2015).
Article CAS PubMed PubMed Central Google Scholar
Dirice, E. et al. Inhibition of DYRK1A stimulates human β-cell proliferation. Diabetes 65, 1660–1671 (2016).
Article CAS PubMed PubMed Central Google Scholar
Shen, W. et al. Inhibition of DYRK1A and GSK3B induces human β-cell proliferation. Nat. Commun. 6, 8372 (2015).
Article CAS PubMed Google Scholar
Wang, P. et al. Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells. J. Clin. Invest. 132, e157086 (2022).
Article CAS PubMed PubMed Central Google Scholar
Ackeifi, C. et al. Pharmacologic and genetic approaches define human pancreatic β cell mitogenic targets of DYRK1A inhibitors. JCI Insight 5, e132594 (2020).
Article PubMed PubMed Central Google Scholar
Kumar, K. et al. Development of kinase-selective, harmine-based DYRK1A inhibitors that induce pancreatic human β-cell proliferation. J. Med. Chem. 61, 7687–7699 (2018).
Article CAS PubMed PubMed Central Google Scholar
Boerner, B. P., George, N. M., Targy, N. M. & Sarvetnick, N. E. TGF-β superfamily member nodal stimulates human β-cell proliferation while maintaining cellular viability. Endocrinology 154, 4099–4112 (2013).
Article CAS PubMed PubMed Central Google Scholar
Wang, H. et al. Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas. Nat. Commun. 8, 767 (2017).
Article CAS PubMed PubMed Central Google Scholar
El-Gohary, Y. et al. A smad signaling network regulates islet cell proliferation. Diabetes 63, 224–236 (2014).
Article CAS PubMed Google Scholar
Dhawan, S., Dirice, E., Kulkarni, R. N. & Bhushan, A. Inhibition of TGF-β signaling promotes human pancreatic β-cell replication. Diabetes 65, 1208–1218 (2016).
Article CAS PubMed PubMed Central Google Scholar
Wang, P. et al. Combined inhibition of DYRK1A, SMAD, and Trithorax pathways synergizes to induce robust replication in adult human beta cells. Cell Metab. 29, 638–652 (2019).
Article CAS PubMed Google Scholar
Pisharath, H., Rhee, J. M., Swanson, M. A., Leach, S. D. & Parsons, M. J. Targeted ablation of beta cells in the embryonic zebrafish pancreas using E. coli nitroreductase. Mech. Dev. 124, 218–229 (2007).
Article CAS PubMed Google Scholar
Curado, S. et al. Conditional targeted cell ablation in zebrafish: a new tool for regeneration studies. Dev. Dyn. 236, 1025–1035 (2007).
Article CAS PubMed Google Scholar
Schulz, N. et al. Critical role for adenosine receptor A2a in beta-cell proliferation. Mol. Metab. 5, 1138–1146 (2016).
Article CAS PubMed PubMed Central Google Scholar
Andersson, O. et al. Adenosine signaling promotes regeneration of pancreatic β-cells in vivo. Cell Metab. 15, 885–894 (2012).
Article CAS PubMed PubMed Central Google Scholar
Annes, J. P. et al. Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication. Proc. Natl Acad. Sci. USA 109, 3915–3920 (2012).
Article CAS PubMed PubMed Central Google Scholar
Prentice, K. J. et al. A hormone complex of FABP4 and nucleoside kinases regulates islet function. Nature 600, 720–726 (2021).
Comments (0)